Onalabs, a CataloniaBio & HealthTech member, has received a Startup Capital grant from ACCIÓ for €75,000 to kick off their initial business plan.
The start-up has opened a round of funding to speed launch to market of its non-invasive device that monitors lactate in athletes’ sweat to assess their physical conditions at all times and optimise performance using an app for mobile phones or smart watches. Lactate is currently measured using a blood test.
Onalabs has developed its own sensor technology platform for remote monitoring of biomarkers.
As CEO Josep Cardona explained, the company expects to begin marketing the device late this year, targeting both amateur and high-performance athletes, as well as doctors.
Comments